Skip to main content

Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · IEX Real-Time Price · USD
1.86 0.00 (0.00%)
Oct 25, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018
Revenue
0.71.124.04
Revenue Growth
-37.79%-72.22%-
Gross Profit
0.71.124.04
Selling, General & Admin
2.624.272.52
Research & Development
0.892.553.65
Operating Expenses
3.526.826.16
Operating Income
-2.82-5.7-2.12
Interest Expense / Income
0.030.020.03
Pretax Income
-2.85-5.72-2.15
Net Income
-2.85-5.72-2.15
Net Income Common
-2.85-5.72-2.15
Shares Outstanding (Basic)
888
Shares Outstanding (Diluted)
888
Shares Change
0.39%2.08%-
EPS (Basic)
-0.35-0.70-0.27
EPS (Diluted)
-0.35-0.70-0.27
Free Cash Flow Per Share
-0.14-0.040.09
Gross Margin
100.00%100.00%100.00%
Operating Margin
-403.52%-507.52%-52.52%
Profit Margin
-407.73%-509.73%-53.27%
Free Cash Flow Margin
-161.69%-30.13%17.69%
EBITDA
-2.82-5.7-2.12
EBITDA Margin
-403.52%-507.52%-52.52%
EBIT
-2.82-5.7-2.12
EBIT Margin
-403.52%-507.52%-52.52%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).